Tang Capital Management’s Century Therapeutics IPSC Stock Holding History

Tang Capital Management’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-900,000	Closed	-$448K	–	131
2025 Q3	$448K	Hold	900,000	–	–	0.02%	181
2025 Q2	$503K	Hold	900,000	–	–	0.03%	187
2025 Q1	$428K	Hold	900,000	–	–	0.02%	188
2024 Q4	$909K	Hold	900,000	–	–	0.06%	157
2024 Q3	$1.54M	Hold	900,000	–	–	0.11%	100
2024 Q2	$2.29M	Hold	900,000	–	–	0.23%	76
2024 Q1	$3.76M	Sell	900,000 -166,440	-16%	-$704K	0.39%	65
2023 Q4	$3.54M	Buy	+1,066,440	New	+$1.94M	0.33%	72

Other funds holding IPSC

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

SSC

Spruce Street Capital New York $510M AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Tang Capital Management's IPSC Position: Q4 2025 in Review

Tang Capital Management sold out of Century Therapeutics (IPSC) in Q4 2025, closing a stake of 900,000 shares — an estimated $448K sold.

Tang Capital Management first reported a position in IPSC in Q4 2023 and held it in 8 quarters. The position peaked at $3.76M in Q1 2024. 47 funds tracked by Wall St. Rank hold IPSC as of Q4 2025.

Tang Capital Management reported no remaining Century Therapeutics position as of Q4 2025 after selling out during the quarter.
Tang Capital Management sold 900,000 Century Therapeutics shares in Q4 2025, an estimated $448K.
Tang Capital Management first reported a position in Century Therapeutics in Q4 2023 and held it in 8 quarters.
Tang Capital Management's Century Therapeutics position peaked at $3.76M in Q1 2024.
47 funds tracked by Wall St. Rank held Century Therapeutics as of Q4 2025.

Based on Tang Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.